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To study the trypanocidal, antibacterial, antifungal activity and cytotoxicity of myxomycetes, a 
rapid assessment focused on the species Physarella oblonga was carried out. Optimum conditions 
for culturing were utilized to develop a protocol that was adequate for bioanalysis of chemical 
compounds. Nuclear magnetic resonance (NMR) and mass spectroscopy (MS) detected the 
presence of stigmasterol and fatty acids in plasmodial extracts of Ph. oblonga through H1 analysis. 
These plasmodial extracts showed low toxicity and positive activity against epymastigote forms of 
Trypanosoma cruzi. This activity was significantly higher than the activity shown by one of the 
controls used. Similarly, the extracts from an unidentified species of myxomycete showed strong 
antimicrobial and antifungal activities against isolated strains of Bacillus cereus, Fusarium 
oxysporum and Rhizoctonia solani, whereas the myxomycete Physarum melleum displayed growth 
inhibition of the phytopathogen F. oxysporum. These results showed that with the use of an 
appropriate methodology, bioprospective analysis can be carried out on myxomycetes. In addition, 
this is apparently the first report on the antifungal and antiparasitic potential of myxomycetes. 
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Introduction 
 The myxomycetes, also known as slime 
molds or myxogastrids, are a group of 
approximately 850 amoeboid protists (Lado 
2005-2011) that occur in all terrestrial 
ecosystems but are poorly studied in some 
regions of the world. Myxomycetes are heterot-
rophic organisms that resemble certain micro-
scopic fungi and produce spores as their 
primary dispersal mechanism (Stephenson & 
Stempen 1994). Their life cycle includes two 
different trophic stages, a uninucleate cell often 
referred to as a myxoamoeba or swarm cell, 
depending on the presence or absence of a 
flagellum, and a macroscopic, multinucleate 
structure known as a plasmodium (Martin & 
Alexopoulos 1969). 
 Myxomycetes are unique organisms 
from a biochemical point of view (Steglich 
1989). This is partially due to the presence of a 
large group of secondary metabolites, some of 
which have been isolated from several of the 
more commonly cultured species. Among these 
metabolites, a number of fatty acid derivatives, 
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alkaloids, aromatic compounds, terpenoids and 
amides have been identified (Dembitsky et al. 
2005). Interestingly, the derivates from fatty 
acids are known for their antimicrobial activity, 
which exhibits a reversal effect of multidrug 
resistance (Ishibashi et al. 2001, Misono et al. 
2003, Nakatani et al. 2005). These facts cause 
myxomycetes to be a very interesting and inno-
vative group to be analyzed from a biochemical 
perspective. 
 Similarly, their secondary metabolic 
pathways produce compounds with unique 
structures, and these compounds resemble a 
series of metabolites from both plants and 
fungi. However, a standard procedure for 
obtaining cultures of these microorganisms has 
not yet been standardized. Therefore, the 
availability of these chemical compounds is 
very low. In fact, most of the studies of spore 
germination, culturing and fruiting body 
formation in myxomycetes were carried out 
more than 40 years ago (Gray 1949) and few, if 
any, studies on secondary metabolites are still 
being carried out in the Western Hemisphere. 
 In spite of this, one group of 
myxomycetes that has been successfully cultu-
red is the order Physarales (Gray & 
Alexopoulos 1968, Lado et al. 2007). Some 
species in this group, such as Physarum 
polycephalum, have even become model 
organisms. However, most of the species in 
this group are still understudied at the 
laboratory level. One of the species in the 
group, Physarella oblonga, has been cultured 
for a number of different purposes (e.g. Franke 
1967, Bechtel 1975, Ribeiro et al. 2003) but 
apparently not yet examined for the presence of 
potentially useful active substances. The same 
can be said for the majority of myxomycetes.  
 This fact does not really represent a 
problem in relation to the search of alternative 
cures for diseases, but it does represent a gap in 
a line of research with a potentially high social 
impact. For instance, diseases such as the 
American Trypanosomiasis, also known as 
Chagas disease, have been traditionally treated 
with potent chemicals, but it has been poorly 
investigated with respect to the use of more 
natural medicines (e.g. Ferraz et al. 2009). 
Since more than 40 million people are at risk of 
being infected with this disease (Schofield 
2006) and its eradication has been difficult, 
there is a need and responsibility to try new 
alternatives for its treatment. In this sense, an 
answer to the question as to whether or not 
myxomycetes can be potential candidates for 
research against Chagas-like diseases is still 
unknown, since these organisms have not yet 
been studied in this way. However, as a 
relatively new biological group for bioprospe-
cting research, myxomycetes provide a wide 
spectrum of possibilities due their unique 
biochemistry.  
 For those reasons, the project described 
herein was designed with two main objectives. 
The first was to rapidly assess the biological 
activity and cytotoxicity of some myxomycete 
plasmodia and their secondary metabolites, and 
the second was to develop a suitable protocol 
for the production of large amounts of myxo-
mycete plasmodial mass. The ultimate goal of 
this project is to make available, at some point 
in the future, the material required to evaluate 
active chemical compounds from myxomycetes 




 This study was carried out in the 
Laboratory of Organic Chemistry of Natural 
Products at the University of Antioquia in 
Medellin, Colombia, during 2007 and 2008. 
The morphological concept of species was used 
to identify myxomycetes, following the 
taxonomic treatment of Lado (2005-2011). 
Plasmodia were first cultivated in moist 
chamber cultures following a modification of 
the protocol provided by Stephenson & Stem-
pen (1994).  
 In all cases, plasmodia were placed on 
filter paper (Whatman #1, 90 mm) in a 
standard Petri dish (150 x 15 mm), and a small 
amount of distilled water was added to the 
dish. After approximately 2 weeks, small secti-
ons of the plasmodia were cut off and placed 
on 1.6% water agar plates. The first fruiting 
bodies obtained in this study were deposited in 
the herbarium of the University of Antioquia 
(HUA). 
 For all bioassays, the myxomycete 
Physarella oblonga (Berk. & M.A. Curtis) 
Morgan was used. However, to test the 
antimicrobial activity, two more taxa, Physar-




unidentified species also were utilized. Cultur-
ing conditions were established for the first 
species and then applied to the other two 
myxomycetes as a way of testing the viability 
of the obtained protocol for generating an 
adequate amount of plasmodial extracts for 
bioassay purposes.  
 
Culturing 
 Seven days after the initial growth on 
water agar, an evaluation of the best type of 
media and amount of food for the plasmodial 
cultivation of Ph. oblonga was carried out. For 
the first part, three sections of plasmodia 
approximately 1 cm
2
 in extent were transferred 
onto sets of three plates prepared with eight 
different types of media, for a total of 24 
different cultures. The media types evaluated 
were 1.6% water agar, oatmeal agar, malt 
extract agar, potato dextrose agar (PDA), 
oxytetracycline glucose yeast agar (OGY), 
sabouraud agar, mixed-bark infusion agar and a 
mushroom (Flammulina velutipes) infusion 
agar.  
 To evaluate the amount of food 
necessary to obtain the largest plasmodia, four 
quantities (0.1, 0.2, 0.5 and 1 g) of oatmeal 
flakes previously autoclaved at 121ºC and 15 
lb/atmospheric pressure for 20 minutes, were 
used in bark infusion agar plates. A set of three 
replicates was prepared for each of the four 
quantities, for a total of 12 different cultures. 
The inoculated plasmodia on bark infusion agar 
were subjected to temperature of 26°C. For 
extraction of secondary metabolites, an additi-
onal experiment was carried out to determine 
the kinetic plasmodium growth. During six 
consecutive days, the weight of the plasmodial 
mass was determined on three cultures per day 
after an initial inoculation of eighteen plates of 
bark infusion agar with plasmodia, following 
the best combination of parameters as determi-
ned from the previous experiments.  
 
Extraction of chemical compounds 
 For Ph. oblonga, the chemical 
extraction of secondary metabolites was carried 
out by starting with a mixture consisting of 1.0 
L of 95% ethanol and approximately 50 g of 
fresh plasmodial mass. This step was followed 
by filtration and evaporation of the solvent and 
fractioning of the crude extract (5 g) by column 
chromatography using Merck silica gel 60, 
eluted with 1000 ml of a mixture of 
dichloromethane:methanol (4:1 v/v). Fractions 
were obtained and monitored using thin layer 
chromatography (TLC) on silica gel 60 chrom-
atoplates using dichloromethane:methanol 4:1 
v/v. From the latter plates, candidate fractions 
were recovered and purified using subsequent 
TLC plates (dichloromethane:methanol 4:1 
v/v) and column separation, using Merck silica 
gel 60, eluted with 500 ml of a mixture of 
hexane:ethyl acetate (3:1 v/v). 
 Isolated compounds were analyzed by 
means of nuclear magnetic resonance (NMR) 
analyses, using a Bruker AMX at 300 MHz for 
1H and 75 MHz for 13C. In addition, mass 
spectroscopy (MS) analyses were performed on 
isolated compounds in order to evaluate the 




 For this essay, Jurkat Lat GFP cells 
were used. Approximately 500,000 cells were 
deposited in individual 1 ml wells on a 24-well 
plate. Samples were activated with a concentra-
tion of 100 µg/ml from the fractions of 
plasmodial extracts of Ph. oblonga, a 
polyunsaturated fatty acid and a yellow 
compound from Ph. oblonga plasmodia 
recovered after chromatrography. A negative 
control was also used. Samples were incubated 
for 12 hours at 37 ºC in an atmosphere of 5% 
CO2. The liquid in each well was transferred to 
a microcentrifuge tube in which propidium 
iodide at a concentration of 1 μl/100 μl was 
added. Immediately after this, samples were 
analyzed using a flow cytometer by collecting 
ten thousand events per sample (see Zaritskaya 
et al. 2010). 
 
Trypanocidal activity 
 The activity against Trypanosoma cruzi 
was evaluated by first cultivating a series of 
samples corresponding to the epimastigote 
forms of the Tulahen strain of the parasite at 
26˚C in a liver infusion-tryptose medium 
supplemented with 5% of heat-inactivated fetal 
bovine serum. The parasites in logarithmic 
growing phase were distributed by triplicate in 
96-flat bottom-well microplates at a concentra-
tion of 5 x 10
4
 cells/ml. Each well was exposed 
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to different concentrations of crude plasmodial 
extract and two fractions isolated from crude 
extract of Ph. oblonga at a concentration of 
100, 50 and 25 g/ml, respectively, for a period 
of 72 hours. 
 The anti-trypanosome activity was 
determined by optical count, using an inverted 
microscope. For this, the reference drugs 
utilized correspond to Benznidazole and 
Amphotericin B at a concentration of 10 μg/ml. 
The results of the antiparasite activity are exp-
ressed in terms of IC50, the drug concentration 
that inhibits 50% of the development in the 
parasite. These values were obtained by 
creating a dose-response curve which corresp-
onds to the logarithm of the drug concentration 
versus the percentage of inhibition. 
 
Determination of antimicrobial activity 
 For these series of assays, three species 
of myxomycetes—Ph. oblonga, P. melleum 
and one unidentified species—were used to test 
biological activity of the group on pathogenic 
microorganisms (see Table 1). The cultures of 
these organisms were obtained from the 
Microbiology laboratory at the Universidad de 
Antioquia. The inhibitory effects of the extracts 
produced were tested by performing a disc 
diffusion method (Thitilertdecha et al. 2008).  
 For this, 50 µl of sample solutions at a 
concentration of 0.5 mg/ml (dry residue/vo-
lume of dimethyl sulfoxide, DMSO) were used. 
Three repeats were tested in every inhibition 
experiment. The magnitude of the antimicro-
bial action was assessed by measuring the 
diameter (in mm) of the inhibition zones, in 
relation to those of positive and negative 
controls. The latter were co-assayed by using 
10 μg of Gentamicine and 1g/L of Benomil as 
positive antimicrobial references and plain 
DMSO as negative control. 
 
Statistical analysis 
 In order to evaluate the performance of 
plasmodial growth under the different culturing 
conditions tested, a series of Kruskal-Wallis 
tests was carried out on the respective data. 
This non-parametric test uses ranks to evaluate 
the independence of three or more groups that 
do not necessarily meet the normality 
requirements of similar tests for heterogeneous 
data structure. On the other hand, the cytotox-
icity and trypanocidal activity were tested 
using analysis of variance due the more norm-
ally structured nature of the datasets. In the 
latter instances, effect-size correlation values 
were also calculated to test variability due to 
biological variation (population-based differe-
nces). In all cases, the probability value associ-
ated with the rejection of the null hypothesis 
was 0.05 and all tests were performed using the 
software JPM, version 7.0.2. (SAS 2007). 
 
Results 
 As result of the experiments described 
above, a successful protocol for the laboratory 
cultivation of myxomycete vegetative (plasmo-
dial) mass was obtained. This was based on the 
performance of Ph. oblonga plasmodial gro-
wth, which was observed to take place only on 
water agar, mushroom infusion agar and bark 
infusion agar. Five days after inoculation the 
amounts of fresh plasmodial mass for the three 
positive media types were 0.041, 0.312 and 
0.980 g, respectively. The ranks of plasmodial 
growth were significantly different on both 
water agar and mushroom infusion agar than 
on bark infusion agar (H=7.20, d.f.=2, P<0.05). 
Based on these results, it was determined that 
bark infusion agar was a suitable medium for 
the cultivation of Ph. oblonga. In a similar 
way, the largest plasmodial fresh weight rank 
differences were obtained by using the smallest 
amount of food (H=8.33, d.f.=3, P<0.05). 
 The average fresh weight obtained for 
each day was determined to be 0.039, 0.186, 
0.528, 0.932, 0.856 and 0.715 g from the first 
to the sixth day. There was a progressive 
increase in plasmodial mass until the fourth 
day, after which the plasmodia seemed to 
decrease in mass. Interestingly, the fresh 
weight of the last three days was not 
significantly different (H=5.68, d.f.=2, P>0.05) 
in spite of obvious differences for the entire 
period of time (H=15.9, d.f.=5, P <0.05).
 Chromatographic fractioning, NMR and 
MS analyses allowed the isolation of a large 
number of triglycerides and several polyunsa-
turated fatty acids. However, only one comp-
ound (stigmasterol) could be identified succe-
ssfully using these techniques.  The cytotoxi-




Table 1 Antimicrobial activity of crude extracts and fractions from myxomycetes and positive and 
negative controls. 
 
Sample type Organism used  
 Bs Sa Ec Fo Rs Bc 
Crude extract Physarella oblonga - - - - - - 
Crude extract Physarum melleum - - - ++ +++ - 
Crude extract Unidentified +++ - - +++ +++ - 
Fraction 1 - - - - - - 
Fraction 4 ++ - - - - - 
Gentamicine (0.1 mg/ml) +++ +++ +++ - - - 
Benomil (1 mg/ml) - - - +++ - +++ 
DMSO (50 µl) - - - - - - 
 
Symbols: – no activity, + inhibition zone less than 10 mm, ++ inhibition zone 10-20 mm, +++ inhibition zone greater 
than 20 mm. 
Abbreviations: Bs = Bacillus subtilis, Sa = Staphylococcus aureus, Ec = Escherichia coli, Fo = Fusarium oxysporum, 
Rs = Rhizoctonia solani, Bc = Botrytis cinerea. 
 
fractions isolated from the crude extract from 
plasmodia of Ph.oblonga have low toxicity 
when compared to the negative control (Table 
2) at a concentration of 100 µg/ml. The highest 
percentage of inhibition was observed for one 
of the plasmodial fractions, designated as 
number two, at 22.7%. In spite of the latter, the 
cytotoxicity observed for fractions and extracts 
from Ph. oblonga plasmodia is not signifi-




The trypanocidal activity of Ph. 
oblonga is shown in Table 3. Both the crude 
extract and the two fractions evaluated showed 
strong differences in the activity against the 
parasite when compared to the Amphotericin B 
control group (for experimental versus control 
only, F(1,2)=1406, P=0.0007, R
2
= 0.99) but no 




In the assays carried out on the 
antimicrobial activity (Table 3), the bacterium 
B. cereus was inhibited by the extract of the 
unidentified myxomycete. The diameter of the 
inhibition zone was about 20 mm at 500 g/ml. 
None of the other combinations of 
myxomycetes and bacteria tested yielded 
positive results. On the other hand, when the 
antifungal activity was tested, both crude 
extracts from P. melleum and the unidentified 
species showed growth inhibition of F. 
oxysporum, although the inhibition zone of the 
latter was larger than that of P. melleum. In the 
case of both antibacterial and antifungal 
activity, the positive controls showed a strong 
effect on the target organisms. Interestingly, 
the strain of R. solani used in this study seemed 
to be very resistant to the different antifungal 
agents used, except in the case of plasmodial 




 The production of fruiting bodies by 
Ph. oblonga only in water agar, mushroom 
infusion agar and bark infusion agar is not 
surprising. It is well known that myxomycete 
spores germinate when water is available 
(Stephenson & Stempen 1994). Also, bark 
represents one of the best substrates on which 
myxomycetes can grow (see Ing 1994) under 
natural conditions. This is probably related to 
the chemical composition of bark from 
different tree species and also to the capacity of 
different types of bark to retain air-borne 
myxomycete spores. As such, it is very likely 
that some myxomycetes are well adapted to 
this corticolous environment and exploit its 
microresources efficiently. If this is the case, 
the Physarales, the order that contains Ph. 
oblonga, is likely to be one example of this 
type of situation, as can be observed in its high 
degree of specificity for bark (see Everhart & 
Keller 2008). Even though mushrooms are also 
known as a substrate for myxomycetes, the 
relationship does not seem to be that intricate  
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Table 2 Percentage of inhibition of Jurkat Lat GF cells shown by different fractions extracted from 
the myxomycete Physarella oblonga.  
 
Fraction Inhibition (%) 
Polyunsaturated fatty acid 22.7 
Unidentified compound 12.4 
Fraction 1 15.2 
Fraction 2 27.0 
Fraction 3 11.6 
Fraction 4 16.7 
Negative control 6.1 
 
(Ing 1994). The fact that fatty acids and 
stigmasterol were successfully isolated from 
myxomycete plasmodia provides some 
evidence that these organisms can be used for 
biosprospecting. Even though these types of 
metabolites already have been reported from 
myxomycete plasmodia (Dembitsky et al. 
2005), this is the first time that stigmasterol has 
been reported for Ph. oblonga. This compound 
has been found in other members of the 
Physarales such as Physarum polycephalum 
and Physarum flavicomum (Bullock & Dawson 
1976). The problem is that these sterols are 
very common in plants as well (e.g. Shibuya 
2001), which makes the evaluation of the 
nature of this compound difficult in the case of 
the present study. Whether this compound is 
being directly produced by the myxomycete or 
actively taken up from the woody substrates is 
a question that warrants additional study. For 
example, stigmasterol is known to occur in oat 
plants, but it also has been observed in 
examples of the Physarales cultured without 
this as a food source (Bullock 1976). It is likely 
that the metabolic pathway used by 
myxomycetes to produce this sterol is very 
similar to the one found in plants (e.g. Schaller 
2004), but the true nature of the compound in 
the cultures we studied remains uncertain for 
now. 
 On the other hand, even though 
polyunsaturated fatty acids are known to 
possess antibacterial activity (e.g. McGaw et 
al. 2002), it is currently impossible to 
determine whether or not some of the 
compounds extracted from Ph. oblonga have 
such properties. However, it seems possible 
that this is indeed the case. For example, 
Chiappeta et al. (1999) reported antibacterial 
activity in Fuligo septica, a species that is 
phylogenetically related to Ph. oblonga. 
Similarly, Lycogala epidendrum has been 
reported to produce fatty acids that showed 
inhibitory activities toward the growth of gram-
positive bacteria (Rezanka & Dvorakova 
2003). What makes bioprospecting in 
myxomycetes more interesting is that it has 
been suggested that fatty acids can be used for 
other important applications. For example, it 
seems that these compounds have a high 
potential for use against malaria, tuberculosis 
and fungal diseases (Carballeira 2008). 
Interestingly, even though there are no studies 
of trypanocidal activity in any of these 
compounds, the results obtained in the present 
investigation provide an alternative future 
approach to study Chagas disease as well.  
 This alternative is of course highly 
dependent on the properties of the system 
analyzed. For example, whether or not a 
system shows toxicity against human cells is 
something critical to be determined. In the 
present study, all the cytotoxicity tests showed 
that plasmodial extracts from Ph. oblonga are 
highly innocuous. This is an important aspect 
to consider in biochemical systems when 
potential medical uses are studied. It has been 
known for a number of years that 
myxomycetes do not have an adverse effect on 
humans (see Stephenson & Stempen 1994), but 
their properties at the cellular level have not 
been studied completely. The low levels of 
cytotoxicity observed in this investigation are 
important since they support the idea that this 
group of non-toxic organisms can be used for 
bioprospecting research. 
The results from the trypanocidal 
activity tests support the latter as well. Even 
though they do not show differences when the 
experimental treatments are compared to 
Benznidazole, the significant differences with 




Table 3 Trypanocide activity of the crude extract and fractions from Physarella oblonga 
plasmodium on epimastigotes of Trypanosoma cruzi. 
 
Sample type Compound IC50- µg/ml 
Crude extract NH-MX-A 7.5 ± 0.14 
Fraction 1 NH-MX-1A 7.8 ± 0.14 
Fraction 2 NH-MX-2A 7.8 ± 0.07 
Reference Amphotericin B 0.2 
Reference Benznidazole 10 
 
potential use of myxomycete plasmodia against 
T. cruzi. Of course, developing a more 
comprehensive research protocol is necessary 
to evaluate this effect more carefully. However, 
the indication of a possible positive effect 
against the parasite as shown herein is 
important, since myxomycetes have not been 
reported previously to be active against any 
type of human parasite. Also, in the fight 
against this disease, any new empirical data 
supporting potential new lines of research are 
helpful for setting the stage for future 
investigations. 
 The unidentified myxomycete showed a 
great inhibitory activity against some of the 
organisms tested. Interestingly, in a manner 
similar to one of the other species, it seems that 
the crude extract is more bioactive than the 
fractioned one. The low level of biological 
activity against bacteria and fungi in the case of 
Ph. oblonga contrasts dramatically with the 
high level of activity against T. cruzi. However,  
in the present study, it was not possible to 
evaluate this aspect completely, since a more 
detailed approached would have to have been 
followed. In any case, what seems likely is that 
distinct species of myxomycetes have different 
types and levels of biological activity, which 
may account for their individual strategies to 
cope with different biotic elements of their 
environment. 
 It is evident that future studies are 
necessary to provide the evidence required to 
fill in the information gaps that exist today. In 
spite of this, the present investigation 
represents a first step in the study of one 
additional group of non-traditional organisms 
with potential applications. The successful 
evaluation of culturing conditions and the 
isolation, using NMR, of some secondary 
metabolites in Ph. oblonga represents a step 
forward in the bioprospecting study of 
myxomycetes with the use of modern research 
tools. At the same time, the evaluation of 
antimicrobial activity displayed by two other 
species of myxomycetes provides an indication 
of the potential use of the group. 
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